
    
      The primary objective of the study is to assess the efficacy of NewGam in correcting the
      platelet count. The secondary objective of the study is to evaluate the safety of NewGam.
      Safety will be assessed by monitoring vital signs, physical examination, evaluation of
      adverse events (AE) and laboratory parameters, and viral safety testing.
    
  